APO Research
Talk to an analyst

APO RESEARCH · REPORT

Leflunomide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Leflunomide Tablets Market Outlook and Growth Opportunities 2026

27 December 2025199 pages

Choose your research edition.

Industry ResearchLeflunomide Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Leflunomide Tablets Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Leflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leflunomide Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Leflunomide Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Leflunomide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Leflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Leflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Leflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Leflunomide Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Leflunomide Tablets market include Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Meiro Pharmaceutical Co., Ltd., Jiangsu Yabang Epson Pharmaceutical Co., Ltd., Hebei Wansui Pharmaceutical Co., Ltd., Fujian Huitian Biopharmaceutical Co., Ltd., Changzhou Watson Pharmaceutical Co., Ltd. and Teva Pharmaceutical Industries Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Leflunomide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Leflunomide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Leflunomide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Leflunomide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Leflunomide Tablets Segment by Company

Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.

Xiamen Lizhuo Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Meiro Pharmaceutical Co., Ltd.

Jiangsu Yabang Epson Pharmaceutical Co., Ltd.

Hebei Wansui Pharmaceutical Co., Ltd.

Fujian Huitian Biopharmaceutical Co., Ltd.

Changzhou Watson Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

Sanofi

Lupin Pharmaceuticals, Inc.

Alembic Pharmaceuticals Inc.

Leflunomide Tablets Segment by Type

Generic Drugs

Original Drugs

Leflunomide Tablets Segment by Application

Hospital

Clinic

Other

Leflunomide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Leflunomide Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Leflunomide Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Leflunomide Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Leflunomide Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leflunomide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leflunomide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leflunomide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Leflunomide Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Leflunomide Tablets industry.

Chapter 3: Detailed analysis of Leflunomide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Leflunomide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Leflunomide Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Leflunomide Tablets Industry Trends Table 2. Leflunomide Tablets Industry Drivers Table 3. Leflunomide Tablets Industry Opportunities and Challenges Table 4. Leflunomide Tablets Industry Restraints Table 5. Global Leflunomide Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Leflunomide Tablets Revenue Share by Company (2021-2026) Table 7. Global Leflunomide Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Leflunomide Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Leflunomide Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Leflunomide Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Leflunomide Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Leflunomide Tablets Company, Product Type & Application Table 13. Global Leflunomide Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Leflunomide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Generic Drugs Table 18. Significant Companies of Original Drugs Table 19. Global Leflunomide Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Leflunomide Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Leflunomide Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Leflunomide Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Leflunomide Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Leflunomide Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Leflunomide Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Leflunomide Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Leflunomide Tablets Sales Value Share by Type (2021-2026) Table 28. Global Leflunomide Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Leflunomide Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Leflunomide Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Leflunomide Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Leflunomide Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Leflunomide Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Leflunomide Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Leflunomide Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Leflunomide Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Leflunomide Tablets Sales Value Share by Application (2021-2026) Table 41. Global Leflunomide Tablets Sales Value Share by Application (2027-2032) Table 42. Global Leflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Leflunomide Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Leflunomide Tablets Sales Market Share by Region (2021-2026) Table 45. Global Leflunomide Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Leflunomide Tablets Sales Market Share by Region (2027-2032) Table 47. Global Leflunomide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Leflunomide Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Leflunomide Tablets Sales Value Share by Region (2021-2026) Table 50. Global Leflunomide Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Leflunomide Tablets Sales Value Share by Region (2027-2032) Table 52. Global Leflunomide Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Leflunomide Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Leflunomide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Leflunomide Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Leflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Leflunomide Tablets Sales Market Share by Country (2021-2026) Table 58. Global Leflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Leflunomide Tablets Sales Market Share by Country (2027-2032) Table 60. Global Leflunomide Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Leflunomide Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Leflunomide Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Leflunomide Tablets Sales Value Market Share by Country (2027-2032) Table 64. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information Table 65. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview Table 66. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 68. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Development Table 69. Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information Table 70. Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview Table 71. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 73. Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Development Table 74. Qilu Pharmaceutical Co., Ltd. Company Information Table 75. Qilu Pharmaceutical Co., Ltd. Business Overview Table 76. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 78. Qilu Pharmaceutical Co., Ltd. Recent Development Table 79. Meiro Pharmaceutical Co., Ltd. Company Information Table 80. Meiro Pharmaceutical Co., Ltd. Business Overview Table 81. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 83. Meiro Pharmaceutical Co., Ltd. Recent Development Table 84. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information Table 85. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview Table 86. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 88. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Development Table 89. Hebei Wansui Pharmaceutical Co., Ltd. Company Information Table 90. Hebei Wansui Pharmaceutical Co., Ltd. Business Overview Table 91. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 93. Hebei Wansui Pharmaceutical Co., Ltd. Recent Development Table 94. Fujian Huitian Biopharmaceutical Co., Ltd. Company Information Table 95. Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview Table 96. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 98. Fujian Huitian Biopharmaceutical Co., Ltd. Recent Development Table 99. Changzhou Watson Pharmaceutical Co., Ltd. Company Information Table 100. Changzhou Watson Pharmaceutical Co., Ltd. Business Overview Table 101. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio Table 103. Changzhou Watson Pharmaceutical Co., Ltd. Recent Development Table 104. Teva Pharmaceutical Industries Ltd. Company Information Table 105. Teva Pharmaceutical Industries Ltd. Business Overview Table 106. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product Portfolio Table 108. Teva Pharmaceutical Industries Ltd. Recent Development Table 109. Sanofi Company Information Table 110. Sanofi Business Overview Table 111. Sanofi Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sanofi Leflunomide Tablets Product Portfolio Table 113. Sanofi Recent Development Table 114. Lupin Pharmaceuticals, Inc. Company Information Table 115. Lupin Pharmaceuticals, Inc. Business Overview Table 116. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product Portfolio Table 118. Lupin Pharmaceuticals, Inc. Recent Development Table 119. Alembic Pharmaceuticals Inc. Company Information Table 120. Alembic Pharmaceuticals Inc. Business Overview Table 121. Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Alembic Pharmaceuticals Inc. Leflunomide Tablets Product Portfolio Table 123. Alembic Pharmaceuticals Inc. Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Leflunomide Tablets Distributors List Table 127. Leflunomide Tablets Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Leflunomide Tablets Product Image Figure 2. Global Leflunomide Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Leflunomide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Leflunomide Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Leflunomide Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Generic Drugs Image Figure 10. Original Drugs Image Figure 11. Global Leflunomide Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Leflunomide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Leflunomide Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Leflunomide Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Leflunomide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Leflunomide Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Leflunomide Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Leflunomide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Leflunomide Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Leflunomide Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Leflunomide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Leflunomide Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Leflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Leflunomide Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Leflunomide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Leflunomide Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Leflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Leflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Leflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Leflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Leflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Leflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Leflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Leflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Leflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Leflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Leflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Leflunomide Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Leflunomide Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drugs
  • Original Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  • Xiamen Lizhuo Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Meiro Pharmaceutical Co., Ltd.
  • Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  • Hebei Wansui Pharmaceutical Co., Ltd.
  • Fujian Huitian Biopharmaceutical Co., Ltd.
  • Changzhou Watson Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Lupin Pharmaceuticals, Inc.
  • Alembic Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Leflunomide Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Leflunomide Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Leflunomide Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Leflunomide Tablets Market Dynamics
  1. 2.1 Leflunomide Tablets Industry Trends
  2. 2.2 Leflunomide Tablets Industry Drivers
  3. 2.3 Leflunomide Tablets Industry Opportunities and Challenges
  4. 2.4 Leflunomide Tablets Industry Restraints
3 Leflunomide Tablets Market by Company
  1. 3.1 Global Leflunomide Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Leflunomide Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Leflunomide Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Leflunomide Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Leflunomide Tablets Company Ranking (2024-2026)
  6. 3.6 Global Leflunomide Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Leflunomide Tablets Company Product Type and Application
  8. 3.8 Global Leflunomide Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Leflunomide Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Leflunomide Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Leflunomide Tablets Market by Type
  1. 4.1 Leflunomide Tablets Type Introduction
  2. 4.1.1 Generic Drugs
  3. 4.1.2 Original Drugs
  4. 4.2 Global Leflunomide Tablets Sales Volume by Type
  5. 4.2.1 Global Leflunomide Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Leflunomide Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Leflunomide Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Leflunomide Tablets Sales Value by Type
  9. 4.3.1 Global Leflunomide Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Leflunomide Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Leflunomide Tablets Sales Value Share by Type (2021-2032)
5 Leflunomide Tablets Market by Application
  1. 5.1 Leflunomide Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Leflunomide Tablets Sales Volume by Application
  6. 5.2.1 Global Leflunomide Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Leflunomide Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Leflunomide Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Leflunomide Tablets Sales Value by Application
  10. 5.3.1 Global Leflunomide Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Leflunomide Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Leflunomide Tablets Sales Value Share by Application (2021-2032)
6 Leflunomide Tablets Regional Sales and Value Analysis
  1. 6.1 Global Leflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Leflunomide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Leflunomide Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Leflunomide Tablets Sales by Region (2027-2032)
  5. 6.3 Global Leflunomide Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Leflunomide Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Leflunomide Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Leflunomide Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Leflunomide Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Leflunomide Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Leflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Leflunomide Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Leflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Leflunomide Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Leflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Leflunomide Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Leflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Leflunomide Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Leflunomide Tablets Sales Value Share by Country, 2025 VS 2032
7 Leflunomide Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Leflunomide Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Leflunomide Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Leflunomide Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Leflunomide Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Leflunomide Tablets Sales by Country (2027-2032)
  6. 7.4 Global Leflunomide Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Leflunomide Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Leflunomide Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Leflunomide Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Leflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Leflunomide Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  2. 8.1.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  6. 8.1.5 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Xiamen Lizhuo Pharmaceutical Co., Ltd.
  8. 8.2.1 Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  12. 8.2.5 Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Qilu Pharmaceutical Co., Ltd.
  14. 8.3.1 Qilu Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Meiro Pharmaceutical Co., Ltd.
  20. 8.4.1 Meiro Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Meiro Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  24. 8.4.5 Meiro Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  26. 8.5.1 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  30. 8.5.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hebei Wansui Pharmaceutical Co., Ltd.
  32. 8.6.1 Hebei Wansui Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hebei Wansui Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  36. 8.6.5 Hebei Wansui Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Fujian Huitian Biopharmaceutical Co., Ltd.
  38. 8.7.1 Fujian Huitian Biopharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  42. 8.7.5 Fujian Huitian Biopharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Changzhou Watson Pharmaceutical Co., Ltd.
  44. 8.8.1 Changzhou Watson Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Changzhou Watson Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
  48. 8.8.5 Changzhou Watson Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Teva Pharmaceutical Industries Ltd.
  50. 8.9.1 Teva Pharmaceutical Industries Ltd. Company Information
  51. 8.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
  52. 8.9.3 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product Portfolio
  54. 8.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Leflunomide Tablets Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
  61. 8.11 Lupin Pharmaceuticals, Inc.
  62. 8.11.1 Lupin Pharmaceuticals, Inc. Company Information
  63. 8.11.2 Lupin Pharmaceuticals, Inc. Business Overview
  64. 8.11.3 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product Portfolio
  66. 8.11.5 Lupin Pharmaceuticals, Inc. Recent Developments
  67. 8.12 Alembic Pharmaceuticals Inc.
  68. 8.12.1 Alembic Pharmaceuticals Inc. Company Information
  69. 8.12.2 Alembic Pharmaceuticals Inc. Business Overview
  70. 8.12.3 Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Alembic Pharmaceuticals Inc. Leflunomide Tablets Product Portfolio
  72. 8.12.5 Alembic Pharmaceuticals Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Leflunomide Tablets Value Chain Analysis
  2. 9.1.1 Leflunomide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Leflunomide Tablets Sales Mode & Process
  6. 9.2 Leflunomide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Leflunomide Tablets Distributors
  9. 9.2.3 Leflunomide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst